O 
203.50
+6.43%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in EUR, from our data supplier.
Revenue
€1.22bn
FY2016FY2025
Net income
€49.5m
FY2016FY2025
Free cash flow
€4.8m
FY2016FY2025
Shareholders' equity
€430.7m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €1.22bn | €1.00bn | €1.05bn | €944.5m | €905.0m | €880.3m | €1.00bn | €976.6m | €825.9m | €699.2m |
| Research and development | €24.9m | — | €7.7m | €15.8m | €19.3m | €19.5m | €18.8m | €25.4m | €32.3m | €44.6m |
| Operating income | €66.2m | €12.6m | €125.0m | €65.6m | €47.0m | €41.6m | €49.4m | €47.8m | €48.0m | €42.7m |
| Net income | €49.5m | −€196,000 | €71.3m | €32.2m | €27.5m | €20.9m | €25.5m | €25.0m | €23.4m | €22.2m |
| Diluted earnings per share | 2.72 | -0.01 | 4.12 | 1.86 | 1.58 | 1.20 | 1.47 | 1.43 | 1.34 | 1.27 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | €1.61bn | €1.40bn | €1.34bn | €1.08bn | €960.8m | €912.1m | €931.0m | €753.6m | €719.7m | €682.9m |
| Cash and short-term investments | €220.6m | €124.9m | €149.9m | €128.9m | €98.6m | €94.0m | €91.5m | €48.7m | €60.8m | €57.0m |
| Total liabilities | €1.17bn | €972.1m | €902.1m | €787.3m | €708.2m | €688.8m | €730.2m | €553.6m | €512.4m | €499.3m |
| Debt | €290.6m | €195.4m | €329.2m | €254.9m | €210.2m | €168.6m | €167.5m | €55.7m | €94.3m | €93.5m |
| Shareholders' equity | €430.7m | €396.9m | €409.0m | €268.8m | €234.5m | €206.1m | €181.7m | €177.3m | €187.6m | €168.6m |
| Shares outstanding | 18m | 19m | 17m | 17m | 17m | 17m | 17m | 17m | 17m | 17m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | €28.7m | €159.8m | −€61.8m | €9.1m | −€17.3m | €44.1m | €22.9m | €60.2m | €35.0m | €72.7m |
| Capital spending | −€23.9m | −€15.3m | −€23.8m | −€20.5m | −€22.6m | −€21.2m | −€20.9m | −€24.2m | −€24.7m | −€18.4m |
| Free cash flow | €4.8m | €144.5m | −€85.6m | −€11.4m | −€39.9m | €23.0m | €1.9m | €36.0m | €10.3m | €54.3m |
| Dividends paid | −€11.5m | −€11.5m | −€10.4m | −€8.3m | −€7.5m | −€7.5m | −€7.5m | −€7.0m | −€7.0m | −€7.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €329.2m | €270.9m | €394.7m | €283.9m | €308.2m | €228.7m | €310.1m | €233.1m |
| Operating income | −€152,000 | €15.4m | €10.5m | €23.4m | €22.9m | €9.5m | −€15.9m | €18.9m |
| Net income | −€5.1m | €9.9m | €25.8m | €12.4m | €6.4m | €5.0m | −€17.6m | €12.0m |
| Diluted earnings per share | -0.27 | 0.51 | 1.42 | 0.68 | 0.35 | 0.27 | -0.92 | 0.63 |
| Cash from operations | −€86.0m | −€112.0m | €162.0m | −€22.0m | −€6.0m | −€100.0m | €207.0m | €35.0m |
| Capital spending | −€9.0m | −€7.0m | −€8.0m | −€3.0m | −€4.0m | −€6.0m | −€4.0m | −€3.0m |
| Free cash flow | −€95.0m | −€119.0m | €154.0m | −€25.0m | −€10.0m | −€106.0m | €203.0m | €32.0m |
| Total assets | €2.11bn | €1.49bn | €1.61bn | €1.57bn | €1.57bn | €1.41bn | €1.40bn | €1.48bn |
| Cash and short-term investments | €526.9m | €54.3m | €220.6m | €53.4m | €88.6m | €45.9m | €124.9m | €23.4m |
| Debt | €289.3m | €187.7m | €290.6m | €311.6m | €284.1m | €91.0m | €195.4m | €295.4m |
| Shareholders' equity | €914.9m | €440.5m | €430.7m | €409.3m | €396.9m | €402.2m | €396.9m | €414.8m |
Financial ratios
Data as of 16 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Operating margin | 5.4% | 2.0% | 11.9% | 6.8% | 5.3% | 4.6% | — |
| Net margin | 4.1% | -0.0% | 6.8% | 3.4% | 3.0% | 2.4% | — |
| Return on equity | 11.5% | -0.0% | 17.4% | 12.0% | 11.7% | 10.1% | — |
| Return on assets | 3.1% | -0.0% | 5.3% | 3.0% | 2.9% | 2.3% | — |
| Free cash flow yield | 1.5% | 4.7% | -1.1% | 0.9% | 0.2% | 1.9% | — |
| Revenue growth | 21.4% | -4.4% | 10.9% | 4.4% | 2.8% | -12.4% | — |
| Earnings growth | -25368.9% | -100.3% | 121.1% | 17.3% | 31.8% | -18.3% | — |
| Current ratio | 1.30x | 1.22x | 1.35x | 1.37x | 1.27x | 1.23x | — |
| Debt to equity | 0.67x | 0.43x | 0.73x | 0.81x | 0.71x | 0.59x | — |
| Equity ratio | 26.8% | 28.4% | 30.5% | 24.9% | 24.4% | 22.6% | — |
| Interest coverage | 3.98x | 0.96x | 6.18x | 7.01x | 7.59x | 5.52x | — |
| R&D as a share of sales | 2.0% | — | 0.7% | 1.7% | 2.1% | 2.2% | 1.9% |
| Buybacks as a share of market value | 4.8% | -10.7% | 0.4% | 0.3% | 0.1% | 0.0% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.8% | 6.7% | 5.4% |
| Operating income | 0.3% | 9.7% | 5.1% |
| Net income | 15.4% | 18.9% | 9.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 3.6% | 6.4% | 6.0% | 5.7% |
| Net margin | 2.2% | 3.6% | 3.4% | 3.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 42.9 | -4671.0 | 10.3 | 17.4 | 22.8 | 32.2 | 29.7 | 21.5 | 33.3 | 14.5 |
| Price to sales | 1.8 | 0.9 | 0.7 | 0.6 | 0.7 | 0.8 | 0.8 | 0.6 | 0.9 | 0.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 5 years. Last went ex-dividend on 9 Jun 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.59 | 1.20 | 0.60 | 0.60 | 0.48 | 0.43 | 0.43 | 0.40 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.